THE DOSE

your daily dose of Innovative, trending, and groundbreaking stories from across the cosmos.


SykoActive SykoActive

Ketamine Shows Promise as a Treatment for Various Mental Health Conditions

A recent study conducted by researchers from the University of British Columbia Okanagan and the University of Exeter has shed light on the potential of ketamine in treating a range of mental health disorders, including depression, PTSD, bipolar disorder, and eating disorders. By analyzing over 150 global studies on sub-anesthetic doses of ketamine, the researchers discovered significant anti-depressant and anti-suicidal properties. This breakthrough could pave the way for innovative and more effective mental health treatments.

Read More